Portal:RareDisease/News
From WikiPathways
(Difference between revisions)
| Line 17: | Line 17: | ||
* [[:Pathway:WP4271|Vitamin B12 Disorders]] | * [[:Pathway:WP4271|Vitamin B12 Disorders]] | ||
* [[:Pathway:WP4297|Thiamine Disorders]] | * [[:Pathway:WP4297|Thiamine Disorders]] | ||
| + | * [[:Pathway:WP4236|Disorders of the Krebs Cycle]] | ||
| + | * [[:Pathway:WP4153|Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses]] | ||
| + | * [[:Pathway:WP4220|Neurotransmitter Disorders]] | ||
| + | * [[:Pathway:WP4224|Purine Disorders]] | ||
| + | * [[:Pathway:WP4225|Pyrimidine Disorders]] | ||
Revision as of 14:31, 30 January 2019
Explore rare disease pathways on WikiPathways:
- MECP2 and Associated Rett Syndrome
- Amyotrophic lateral sclerosis (ALS) SOD1 - CHMP2B MODEL
- Fanconi Anemia Pathway
- The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
- Lamin A-processing pathway
- Viral Acute Myocarditis
- Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism
- Tyrosine Metabolism
- Sulphur Amino Acids
- Disorders of Folate Metabolism and Transport
- MTHFR deficiency (additional pathway)
- Vitamine B6-Dependent and Responsive Disorders
- Molybdenum (Moco) cofactor biosynthesis
- Cysteine and Methionine catabolism
- Vitamin B12 Disorders
- Thiamine Disorders
- Disorders of the Krebs Cycle
- Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
- Neurotransmitter Disorders
- Purine Disorders
- Pyrimidine Disorders
